As scientists continue to search high and low for effective COVID-19 treatments, a new modeling study by Japanese resear...
Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) announced that Real Tech Fund (m...
Scientists at Tokyo Institute of Technology (Tokyo Tech) have set out to harness the potential of self-assembling pept...
PHC Corporation has announced that China-based MGI Tech Co., Ltd. develops and manufactures next-generation sequenc...
Japan headquartered Sosei Group Corporation, the world leader in GPCR-focused structure-based drug design...
FUJIFILM Corporation, based in Japan, has announced a ¥90 Billion Yen (~$850 Million) investment package to accelera...
Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....
QIAGEN has announced a global strategic alliance with Japan’s Sysmex Corporation for the development and commercia...
Japanese firms Chugai Pharmaceutical Co., Ltd. and ALBERT Inc, have jointly developed a data scientist training program ...
B dot Medical Inc., a startup based in Japan, has confirmed the superconductivity of a superconducting bending magnet de...
Takara Bio Inc. world leader in biotechnology R&D, announces that it has entered into a License and Supply Agre...
OMRON Healthcare and Kyoto University have announced a new Collaborative Research Program called "Healthc...
The Japan External Trade Organization (JETRO) has announced that 12 major Japanese corporate venture capital g...
Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...
Rakuten Medical, Inc. and Shimadzu Corporation, with operations in both Japan & US, have announced a joint...
Japanese pharma firm Daiichi Sankyo Company has announced that it has decided to discontinue development of nafamostat i...
Taiko Pharmaceutical based in Osaka, Japan, has announced that long-lasting chlorine dioxide (ClO2) aqueous solutio...
Following U.S. Food and Drug Administration’s (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as th...
